600223 Lushang Freda Pharmaceutical
- 6.99
- +0.14+2.04%
Lushang Freda Pharmaceutical News
Freda: Announcement of Lushang Freda Pharmaceutical Co., Ltd. on the cancellation of the pledge of some shares of the controlling shareholder\'s non-public offering of exchangeable corporate bonds
Announcement of Lushang Freda Pharmaceutical Co., Ltd. on the cancellation of the pledge of some shares of the controlling shareholder\'s non-public offering of exchangeable corporate bonds
An indicative announcement by Lushang Freda Pharmaceutical Co., Ltd. on the proposed cancellation of the pledge of some shares of the controlling shareholder\'s non-public offering of exchangeable corporate bonds
Legal Opinion of Guohao Law Firm (Jinan) on the 2024 First Extraordinary General Meeting of Shareholders of Lushang Freda Pharmaceutical Co., Ltd.
Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders of Lushang Freda Pharmaceutical Co., Ltd.
Freda: Meeting materials of the 2024 First Extraordinary General Meeting of Shareholders of Lushang Freda Pharmaceutical Co., Ltd.
Meeting materials of the 2024 First Extraordinary General Meeting of Shareholders of Lushang Freda Pharmaceutical Co., Ltd.
Freda: Notice of Lushang Freda Pharmaceutical Co., Ltd. on holding the 2024 First Extraordinary General Meeting of Shareholders
Notice of Lushang Freda Pharmaceutical Co., Ltd. on convening the 2024 First Extraordinary General Meeting of Shareholders
Minutes of the 2024 Semi-Annual Results Briefing Meeting of Lushang Freda Pharmaceutical Co., Ltd.
Announcement of Lushang Freda Pharmaceutical Co., Ltd. regarding accounting policy changes
Announcement of lushang freda pharmaceutical Co., Ltd. on the convening of the 2024 interim performance briefing.
Announcement of the resolution of the second meeting of the twelfth Board of Supervisors of Lushang Freda Pharmaceutical Co., Ltd.
Announcement of the profit distribution plan for the first half of 2024 of Lushang Freda Pharmaceutical Co., Ltd.
Lushang Freda Pharmaceutical Co., Ltd.'s Risk Continuation Assessment Report on Shandong Commercial Group Finance Co., Ltd.
Announcement of Resolutions of the Second Meeting of the Twelfth Board of Directors of Lushang Freda Pharmaceutical Co., Ltd.
Announcement of the main business data for the second quarter of 2024 by Lushang Freda Pharmaceutical Co., Ltd.
Lushang Freda Pharmaceutical Co., Ltd. 2024 Interim Report
Summary of the semi-annual report of Lushang Freda Pharmaceutical Co., Ltd. in 2024
Announcement of the Implementation of Equity Distribution for Lushang Freda Pharmaceutical Co., Ltd. in 2023.
Analysis
Price Target
No Data
No Data